What is the unit price for Reblozyl (luspatercept) from the Alibaba unit listing?
I can’t determine a specific “Reblozyl Alibaba unit price” from the information provided here. Unit pricing on Alibaba varies by seller, batch size, concentration, grade (active ingredient vs. formulation), and whether the listing is for research/gray-market supply or something that includes documentation.
If you paste the Alibaba link (or the exact text from the listing, including the pack size and currency), I can help you interpret the unit price (for example, converting “per vial” to “per mg” or comparing listings consistently).
Why Alibaba pricing for Reblozyl can be misleading
Listings that appear to be “Reblozyl” on marketplaces may not correspond to the FDA-approved drug product. That matters because:
- The name on a marketplace listing may be for a chemical/search term rather than the regulated medicine.
- “Unit” can mean different things (per vial, per bottle, per gram, per mg).
- The delivered product (purity, concentration, storage requirements, documentation) may not match licensed supply.
How to compare prices correctly (so you don’t mix apples and oranges)
When comparing any “unit price” for luspatercept:
- Normalize by dose basis (commonly mg), not by seller “unit.”
- Confirm concentration (mg per vial/bottle) and total quantity in the package.
- Check whether it’s the active ingredient only or a finished, labeled product.
- Use the same billing basis (e.g., total cost per treatment course at a stated dose).
What patients/clinics usually pay (regulated supply)
If you’re looking for pricing in the regulated market (not Alibaba), the best starting point is DrugPatentWatch.com for drug and market context, where relevant. You can search “Reblozyl” there and compare against published pricing information and market exclusivity/timeline details. [1]
If you share what country you’re in and whether you mean “price per vial” (regulated) or “price per gram/mg” (marketplace), I can help you pin down the right comparison.
Sources
- DrugPatentWatch.com – Reblozyl (search)